These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

651 related items for PubMed ID: 16457809

  • 1. Mechanisms of antiplatelet activity of PC-09, a newly synthesized pyridazinone derivative.
    Cherng SC, Huang WH, Shiau CY, Lee AR, Chou TC.
    Eur J Pharmacol; 2006 Feb 17; 532(1-2):32-7. PubMed ID: 16457809
    [Abstract] [Full Text] [Related]

  • 2. 2-(2-Br-phenyl)-8-methoxy-benzoxazinone (HPW-RX2), a direct thrombin inhibitor with a suppressive effect on thromboxane formation in platelets.
    Wu CC, Wang TW, Wang WY, Hsieh PW, Wu YC.
    Eur J Pharmacol; 2005 Dec 19; 527(1-3):37-43. PubMed ID: 16313903
    [Abstract] [Full Text] [Related]

  • 3. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mechanisms involved in the antiplatelet effect of C-phycocyanin.
    Chiu HF, Yang SP, Kuo YL, Lai YS, Chou TC.
    Br J Nutr; 2006 Feb 15; 95(2):435-40. PubMed ID: 16469164
    [Abstract] [Full Text] [Related]

  • 8. The protective effects of paclitaxel on platelet aggregation through the inhibition of thromboxane A2 synthase.
    Lee JJ, Yu JY, Lee JH, Zhang WY, Kim TJ, Myung CS, Yun YP.
    Arch Pharm Res; 2010 Mar 15; 33(3):387-94. PubMed ID: 20361303
    [Abstract] [Full Text] [Related]

  • 9. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization.
    Lee JJ, Jin YR, Lim Y, Hong JT, Kim TJ, Chung JH, Yun YP.
    Vascul Pharmacol; 2006 Sep 15; 45(3):148-53. PubMed ID: 16916624
    [Abstract] [Full Text] [Related]

  • 10. Antiplatelet activity of J78 (2-Chloro-3-[2'-bromo, 4'-fluoro-phenyl]-amino-8-hydroxy-1,4-naphthoquinone), an antithrombotic agent, is mediated by thromboxane (TX) A2 receptor blockade with TXA2 synthase inhibition and suppression of cytosolic Ca2+ mobilization.
    Jin YR, Cho MR, Ryu CK, Chung JH, Yuk DY, Hong JT, Lee KS, Lee JJ, Lee MY, Lim Y, Yun YP.
    J Pharmacol Exp Ther; 2005 Jan 15; 312(1):214-9. PubMed ID: 15328379
    [Abstract] [Full Text] [Related]

  • 11. Control of platelet activation by cyclic AMP turnover and cyclic nucleotide phosphodiesterase type-3.
    Feijge MA, Ansink K, Vanschoonbeek K, Heemskerk JW.
    Biochem Pharmacol; 2004 Apr 15; 67(8):1559-67. PubMed ID: 15041473
    [Abstract] [Full Text] [Related]

  • 12. The antiplatelet effects of a new nitroderivative of acetylsalicylic acid--an in vitro study of inhibition on the early phase of platelet activation and on TXA2 production.
    Lechi C, Andrioli G, Gaino S, Tommasoli R, Zuliani V, Ortolani R, Degan M, Benoni G, Bellavite P, Lechi A, Minuz P.
    Thromb Haemost; 1996 Nov 15; 76(5):791-8. PubMed ID: 8950792
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Mechanism involved in the antiplatelet activity of naloxone in human platelets.
    Sheu JR, Hung WC, Lee LW, Chang PT, Kan YC, Yen MH.
    Biochem Biophys Res Commun; 1997 Feb 03; 231(1):12-6. PubMed ID: 9070210
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.